Literature DB >> 34951621

Can inpatient pharmacists move the needle on smoking cessation? Evaluating reach and representativeness of a pharmacist-led opt-out smoking cessation intervention protocol for hospital settings.

Paul D Creswell1, Danielle E McCarthy1, Philip Trapskin2, Ann Sheehy3, Amy Skora1, Robert T Adsit1, Mark E Zehner1, Timothy B Baker1, Michael C Fiore1.   

Abstract

PURPOSE: Hospitalization affords an opportunity to reduce smoking, but fewer than half of patients who smoke receive evidence-based cessation treatment during inpatient stays. This study evaluated a pharmacist-led, electronic health record (EHR)-facilitated opt-out smoking cessation intervention designed to address this need.
METHODS: Analyses of EHR records for adult patients who smoked in the past 30 days admitted to an academic medical center in the upper Midwest were conducted using the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework. The reach of a pharmacist-led, EHR-facilitated protocol for smoking cessation treatment was assessed by comparing patients' receipt of nicotine replacement therapy (NRT) and tobacco quitline referral before and after implementation. χ2 tests, t tests, and multiple logistic regression models were used to compare reach across patient demographic groups to assess treatment disparities and the representativeness of reach. Adoption of the program by hospital services was also assessed.
RESULTS: Of the 70 hospital services invited to implement the program, 88.6% adopted it and 78.6% had eligible admissions. Treatment reach increased as rates of delivering NRT rose from 43.6% of eligible patients before implementation to 50.4% after implementation (P < 0.0001) and quitline referral rates rose from 0.9% to 11.9% (P < 0.0001). Representativeness of reach by sex and ethnicity improved after implementation, although disparities by race and age persisted after adjustment for demographics, insurance, and primary diagnosis. Pharmacists addressed tobacco use for eligible patients in 62.5% of cases after protocol implementation.
CONCLUSION: Smoking cessation treatment reach and representativeness of reach improved after implementation of a proactive, pharmacist-led, EHR-facilitated opt-out smoking cessation treatment protocol in adult inpatient services. © American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  electronic health records; healthcare disparities; implementation science; medication reconciliation; pharmacists; tobacco use cessation

Mesh:

Year:  2022        PMID: 34951621      PMCID: PMC9171569          DOI: 10.1093/ajhp/zxab488

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.980


  21 in total

Review 1.  Interventions for smoking cessation in hospitalised patients.

Authors:  Nancy A Rigotti; Carole Clair; Marcus R Munafò; Lindsay F Stead
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Evaluating the impact of health promotion programs: using the RE-AIM framework to form summary measures for decision making involving complex issues.

Authors:  Russell E Glasgow; Lisa M Klesges; David A Dzewaltowski; Paul A Estabrooks; Thomas M Vogt
Journal:  Health Educ Res       Date:  2006-08-31

3.  Cluster-Randomized Trial of Clinical Pharmacist Tobacco Cessation Counseling Among Patients with Cardiovascular Disease.

Authors:  Jody Adams; Alicia A Cymbala; Thomas Delate; Deanna Kurz; Kari L Olson; Morgan Youngblood; Emily Zadvorny
Journal:  Popul Health Manag       Date:  2015-02-03       Impact factor: 2.459

4.  Using the electronic health record to connect primary care patients to evidence-based telephonic tobacco quitline services: a closed-loop demonstration project.

Authors:  Robert T Adsit; Bradley M Fox; Thanos Tsiolis; Carolyn Ogland; Michelle Simerson; Linda M Vind; Sean M Bell; Amy D Skora; Timothy B Baker; Michael C Fiore
Journal:  Transl Behav Med       Date:  2014-09       Impact factor: 3.046

5.  CHARTing the Future Course of Tobacco-Cessation Interventions for Hospitalized Smokers.

Authors:  Nancy A Rigotti; Catherine M Stoney
Journal:  Am J Prev Med       Date:  2016-10       Impact factor: 5.043

6.  Quitting Smoking Among Adults - United States, 2000-2015.

Authors:  Stephen Babb; Ann Malarcher; Gillian Schauer; Kat Asman; Ahmed Jamal
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-06       Impact factor: 17.586

7.  Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings.

Authors:  Philip J Trapskin; Ann Sheehy; Paul D Creswell; Danielle E McCarthy; Amy Skora; Rob T Adsit; Anne E Rose; Candace Bishop; Jessica Bugg; Emily Iglar; Mark E Zehner; Daniel Shirley; Brian S Williams; Adam J Hood; Krista McElray; Timothy B Baker; Michael C Fiore
Journal:  Hosp Pharm       Date:  2021-03-05

8.  Increasing Rates of Tobacco Treatment Delivery in Primary Care Practice: Evaluation of the Ottawa Model for Smoking Cessation.

Authors:  Sophia Papadakis; Adam G Cole; Robert D Reid; Mustafa Coja; Debbie Aitken; Kerri-Anne Mullen; Marie Gharib; Andrew L Pipe
Journal:  Ann Fam Med       Date:  2016-05       Impact factor: 5.166

9.  Factors associated with nicotine replacement therapy use among hospitalised smokers.

Authors:  Chang Yue Chui; Dennis Thomas; Simone Taylor; Billie Bonevski; Michael J Abramson; Eldho Paul; Susan G Poole; Gregory R Weeks; Michael J Dooley; Johnson George
Journal:  Drug Alcohol Rev       Date:  2018-02-07

10.  Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018.

Authors:  MeLisa R Creamer; Teresa W Wang; Stephen Babb; Karen A Cullen; Hannah Day; Gordon Willis; Ahmed Jamal; Linda Neff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-15       Impact factor: 17.586

View more
  1 in total

1.  A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting.

Authors:  Kathryn L Taylor; Randi M Williams; Tengfei Li; George Luta; Laney Smith; Kimberly M Davis; Cassandra A Stanton; Raymond Niaura; David Abrams; Tania Lobo; Jeanne Mandelblatt; Jinani Jayasekera; Rafael Meza; Jihyoun Jeon; Pianpian Cao; Eric D Anderson
Journal:  J Natl Cancer Inst       Date:  2022-10-06       Impact factor: 11.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.